SEONGNAM, South Korea, April 6, 2025 /PRNewswire/ -- ABL Bio Inc. (KOSDAQ: 298380), a clinical-stage biotech company developing bispecific antibody technology for immuno-oncology and neurodegenerative ...
SANTA FE, N.M., Oct. 1, 2025 /PRNewswire/ -- Mercury Bio (www.mercurybio.com), a drug delivery company leveraging its novel and proprietary extracellular vesicle (EV) drug encapsulation platform (yEV™ ...
Highlight brain imaging analysis solutions, including 'Neurophet AQUA AD', which monitors side effects from Alzheimer's disease treatments To accelerate partnering efforts with global pharmaceutical ...
Forbes contributors publish independent expert analyses and insights. Dr. Lance B. Eliot is a world-renowned AI scientist and consultant. In today’s column, I analyze the recently announced ...
JuneBrain Inc., a Baltimore-based neurotech startup, took first place at the 2025 BioChallenge Pitch Competition, held October 30 at the New Orleans BioInnovation Center (NOBIC). The annual contest ...
BrainChild Bio advancing BCB-276 towards BLA submission with a single pivotal Phase 2 trial planned to commence in Q4 2025 SEATTLE & CAMBRIDGE, Mass.--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical ...
A bio-inspired adhesive patch puts some mussel into treating glioblastoma – the most aggressive brain tumor.
X chromosome reactivation contributes to reducing the signs of disease in the female brain. Female cells have two X ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results